Results 31 to 40 of about 1,006,166 (271)
Citation: 'serum sickness' in the IUPAC Compendium of Chemical Terminology, 5th ed.; International Union of Pure and Applied Chemistry; 2025. Online version 5.0.0, 2025. 10.1351/goldbook.13673 • License: The IUPAC Gold Book is licensed under Creative Commons Attribution-ShareAlike CC BY-SA 4.0 International for individual terms.
Rixe N, Tavarez MM.
europepmc +3 more sources
Serum Sickness-Like Reaction: Drug-Induced Cutaneous Disease in a Child [PDF]
Ana Carolina Galvão dos Santos de Araujo +6 more
doaj +2 more sources
Dupilumab-induced serum sickness-like reaction in a pediatric patient [PDF]
S. Minhaj Rahman, BA +4 more
doaj +2 more sources
Serum sickness–like reaction associated with mirabegron [PDF]
Marcus G Tan +2 more
exaly +2 more sources
Pathophysiology and clinical manifestations of immune complex vasculitides
Immune complex (IC) vasculitides present inflammations of vessel walls associated with perivascular deposition of immunoglobulins (Igs), mostly ICs. They encompass systemic and skin-limited variants of IgA vasculitis (IgAV), cryoglobulinemic vasculitis ...
Cord Sunderkötter +3 more
doaj +1 more source
Serum Sickness-Like Reaction Associated with Epstein – Barr Virus: Clinical Case
Background. Annular dermatoses are a group of diseases with major clinical manifestation of rashes of relevant form. This manifestation pattern causes difficulties in diagnosis.
Vladislav V. Ivanchikov +3 more
doaj +1 more source
Detection of trypanosomes in small ruminants and pigs in western Kenya: important reservoirs in the epidemiology of sleeping sickness? [PDF]
Background Trypanosomosis is a major impediment to livestock farming in sub-Saharan Africa and limits the full potential of agricultural development in the 36 countries where it is endemic.
Musa O Ng'ayo +11 more
core +1 more source
Several monoclonal antibodies have been approved by the Food and Drug Administration (FDA) to treat allergic disorders, including omalizumab, dupilumab, mepolizumab, reslizumab, benralizumab, tralokinumab and tezepelumab, and their indications continue ...
Andrea Sitek +2 more
doaj +1 more source
Correction: Serum sickness-like reaction to D-Supplement: A Case Report [PDF]
Emma R. Plante +3 more
doaj +2 more sources

